A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: unlimited (6), endless (3)

NIHR_RTB_PIS-ICF_v4.1_15Mar2023Localised

Description
2 PARTICIPANT INFORMATION SHEET The NIHR BioResource Research Tissue Bank Version 4.1 15th March 2023 *If you requi
Url
/Media/Southampton-Clinical-Research/Downloads/NIHR-RTB-PIS-ICF-v4.1-15Mar2023Localised.docx

InP-Cisplatin-Doxorubicin-Methotrexate (1-4)

Description
Chemotherapy Protocol Sarcoma CISPLATIN-DOXORUBICIN-METHOTREXATE (cycles 1-4) Inpatient Regimen There are multiple versions of th
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Cisplatin-Doxorubicin-Methotrexate-1-4.pdf

Carboplatin(AUC6)-Paclitaxel-Pembrolizumab

Description
Chemotherapy Protocol LUNG CANCER CARBOPLATIN (AUC6)-PACLITAXEL-PEMBROLIZUMAB Regimen • Lung-Carboplatin (AUC6)-Paclitaxel-Pembrolizumab Indication - The patient has a his
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CarboplatinAUC6-Paclitaxel-Pembrolizumab.pdf

InP-ICE-Carboplatin-Etoposide-Ifosfamide

Description
Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE (ICE) Inpatient Regimen Regimen • Lymphoma – InP-ICE-Carboplatin-Etopos
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-ICE-Carboplatin-Etoposide-Ifosfamide.pdf

InP (RICE) Carboplatin Etoposide Ifosfamide Rituximab

Description
Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RICE) Inpatient Regimen Regimen • Lymphoma – InP-RICE-Carboplati
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RICE-Carboplatin-Etoposide-Ifosfamide-Rituximab.pdf

AmB Carboplatin Etoposide Ifosfamide Rituximab (RICE)

Description
Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RICE) Ambulatory Regimen Regimen • Lymphoma – AmB-RICE-Carboplat
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-Carboplatin-Etoposide-Ifosfamide-Rituximab-RICE-Ver1.1.pdf

Finance and Performance Reports 2022-23 Month 2 May 2022

Description
Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose Issue to be addressed: Finance
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Finance-and-Performance-Reports-2022-23-Month-2-May-2022.pdf

Atezolizumab-Bevacizumab-Carboplatin(AUC6)-Paclitaxel

Description
Chemotherapy Protocol LUNG CANCER ATEZOLIZUMAB-BEVACIZUMAB-CARBOPLATIN (AUC6)-PACLITAXEL Regimen  Lung-Atezolizu
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Atezolizumab-Bevacizumab-CarboplatinAUC6-Paclitaxel.pdf

Going home after your stay at the major trauma centre - patient information

Description
This factsheet gives you useful information about returning home after your stay at the trauma centre.
Url
/Media/UHS-website-2019/Patientinformation/Major-Trauma-Centre/Going-home-after-your-stay-at-the-major-trauma-centre-3124-PIL.pdf

Transient ischemic attack (TIA) - patient information

Description
Transient ischemic attack (TIA) Information for patients You have been given this booklet because you have bee
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Transient-ischemic-attack-TIA-685-PIL.pdf
321 to 330 of 376
Previous … 31 32 33 34 35 … Next